Colfax Corp. (CFX) Tops Q4 EPS by 5c, Revenues Beat; Offers FY20 EPS Mid-Point Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. HUM
8. NVDA
9. CSCO
10. KTOS

Go back to Colfax Corp. (CFX) Tops Q4 EPS by 5c, Revenues Beat; Offers FY20 EPS Mid-Point Guidance Below Consensus

Colfax Reports Fourth Quarter 2019 Results

February 21, 2020 6:00 AM EST

        Reported $0.24 EPS from continuing operations and achieved $0.61 of adjusted EPS

        Delivered 7.5% year-on-year sales growth in Medical Technology segment including 7.8% organic improvement

        Improved Fabrication Technology operating income and adjusted EBITA margins by over 300 basis points

        Reaffirming 2020 adjusted EPS guidance of $2.10 to $2.20

ANNAPOLIS JUNCTION, MD, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the fourth quarter of 2019.

The Company reported net income from continuing operations of $33 million or $0.24 per share in the quarter, and $83 million of adjusted... More